宫颈癌诊疗指南 (2022年版)

2022-04-11 国家癌症中心 卫健委官网

子宫颈癌是常见的妇科恶性肿瘤之一,发病率在我国女性恶性肿瘤中居第二位,位于乳腺癌之后。2018年全球新发子宫颈癌病例超过56.9万例,死亡病例超过31.1万例。其中85%的病例发生于发展中国家。我国2

中文标题:

宫颈癌诊疗指南 (2022年版)

发布机构:

国家癌症中心

发布日期:

2022-04-11

简要介绍:

子宫颈癌是常见的妇科恶性肿瘤之一,发病率在我国女性恶性肿瘤中居第二位,位于乳腺癌之后。2018年全球新发子宫颈癌病例超过56.9万例,死亡病例超过31.1万例。其中85%的病例发生于发展中国家。我国2015年约有新发病例11.1万,死亡病例3.4万。我国子宫颈癌死亡分布情况总体上农村略高于城市,中西部地区约为东部地区的两倍。我国子宫颈癌患者中位发病年龄是51岁,但主要好发于2个年龄段,以4050岁为最多,6070岁又有一高峰出现,20岁以前少见。然而值得关注的是近年来子宫颈癌的平均发病年龄在逐渐降低,有年轻化趋势。因此,十分有必要在全国范围内规范宫颈癌的诊断与治疗。另一方面,宫颈癌的发生可通过对癌前病变的检查和处理得以有效控制。西方国家的经验显示,宫颈癌的发生率在密切筛查的人群中减少了70%~90%20201117日,WHO启动了“加速消除宫颈癌”的全球战略。

相关资料下载:
[AttachmentFileName(sort=1, fileName=宫颈癌诊疗指南 (2022年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=d86de1c002a114dc, title=宫颈癌诊疗指南 (2022年版), enTitle=, guiderFrom=卫健委官网, authorId=0, author=, summary=子宫颈癌是常见的妇科恶性肿瘤之一,发病率在我国女性恶性肿瘤中居第二位,位于乳腺癌之后。2018年全球新发子宫颈癌病例超过56.9万例,死亡病例超过31.1万例。其中85%的病例发生于发展中国家。我国2, cover=https://img.medsci.cn/20220414/1649877807172_5579292.png, journalId=0, articlesId=null, associationId=1931, associationName=国家癌症中心, associationIntro=国家癌症中心, copyright=0, guiderPublishedTime=Mon Apr 11 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">子宫颈癌是常见的妇科恶性肿瘤之一</span><span style="color: #000000;">,</span><span style="color: #000000;">发病率在我国女性恶性肿瘤中居第二位</span><span style="color: #000000;">,</span><span style="color: #000000;">位于乳腺癌之后。</span><span style="color: #000000;">2018</span><span style="color: #000000;">年全球新发子宫颈癌</span><span style="color: #000000;">病例超过</span><span style="color: #000000;">56.9</span><span style="color: #000000;">万例,死亡病例超过</span><span style="color: #000000;">31.1</span><span style="color: #000000;">万例。其中</span><span style="color: #000000;">85%</span><span style="color: #000000;">的病例发生于发展中国家。我国</span><span style="color: #000000;">2015</span><span style="color: #000000;">年约有新发病例</span><span style="color: #000000;">11.1</span><span style="color: #000000;">万,死亡病例</span><span style="color: #000000;">3.4</span><span style="color: #000000;">万。我国子宫颈癌死亡分布情况总体上农村略高于城市,中西部地区约为东部地区的两倍。我国子宫颈癌患者中位发病年龄是</span><span style="color: #000000;">51</span><span style="color: #000000;">岁,但主要好发于</span><span style="color: #000000;">2</span><span style="color: #000000;">个年龄段,以</span><span style="color: #000000;">40</span><span style="color: #000000;">~</span><span style="color: #000000;">50</span><span style="color: #000000;">岁为最多,</span><span style="color: #000000;">60</span><span style="color: #000000;">~</span><span style="color: #000000;">70</span><span style="color: #000000;">岁又有一高峰出现,</span><span style="color: #000000;">20</span><span style="color: #000000;">岁以前少见。然而值得关注的是近年来子宫颈癌的平均发病年龄在逐渐降低,有年轻化趋势。因此,十分有必要在全国范围内规范宫颈癌的诊断与治疗。另一方面,宫颈癌的发生可通过对癌前病变的检查和处理得以有效控制。西方国家的经验显示,宫颈癌的发生率在密切筛查的人群中减少了</span><span style="color: #000000;">70%~90%</span><span style="color: #000000;">。</span><span style="color: #000000;">2020</span><span style="color: #000000;">年</span><span style="color: #000000;">11</span><span style="color: #000000;">月</span><span style="color: #000000;">17</span><span style="color: #000000;">日,</span><span style="color: #000000;">WHO</span><span style="color: #000000;">启动了&ldquo;加速消除宫颈癌&rdquo;的全球战略。</span></p>, tagList=[TagDto(tagId=1402, tagName=宫颈癌), TagDto(tagId=1983, tagName=妇科肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12317, appHits=691, showAppHits=0, pcHits=2680, showPcHits=11610, likes=5, shares=97, comments=18, approvalStatus=1, publishedTime=Thu Apr 14 15:22:00 CST 2022, publishedTimeString=2022-04-11, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Apr 14 03:26:21 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 21:31:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=宫颈癌诊疗指南 (2022年版).pdf)])
宫颈癌诊疗指南 (2022年版).pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1238388, encodeId=2ce51238388b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff938274145, createdName=ms5000002136736266, createdTime=Fri Aug 12 22:49:44 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223858, encodeId=47bf12238589a, content=点个赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Wed Jun 01 15:14:55 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222810, encodeId=0a7c122281044, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/73dbf0704dfb6999779d37bdce402b75.jpg, createdBy=4d1f5252601, createdName=蒋师兄, createdTime=Fri May 27 15:31:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222752, encodeId=6b301222e524f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri May 27 09:56:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221108, encodeId=9dca12211085b, content=挺有用的,刚发现这个APP, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1556233736, createdName=155755_9823, createdTime=Fri May 20 09:50:14 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-08-12 ms5000002136736266

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1238388, encodeId=2ce51238388b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff938274145, createdName=ms5000002136736266, createdTime=Fri Aug 12 22:49:44 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223858, encodeId=47bf12238589a, content=点个赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Wed Jun 01 15:14:55 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222810, encodeId=0a7c122281044, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/73dbf0704dfb6999779d37bdce402b75.jpg, createdBy=4d1f5252601, createdName=蒋师兄, createdTime=Fri May 27 15:31:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222752, encodeId=6b301222e524f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri May 27 09:56:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221108, encodeId=9dca12211085b, content=挺有用的,刚发现这个APP, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1556233736, createdName=155755_9823, createdTime=Fri May 20 09:50:14 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-06-01 Mario

    点个赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1238388, encodeId=2ce51238388b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff938274145, createdName=ms5000002136736266, createdTime=Fri Aug 12 22:49:44 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223858, encodeId=47bf12238589a, content=点个赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Wed Jun 01 15:14:55 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222810, encodeId=0a7c122281044, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/73dbf0704dfb6999779d37bdce402b75.jpg, createdBy=4d1f5252601, createdName=蒋师兄, createdTime=Fri May 27 15:31:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222752, encodeId=6b301222e524f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri May 27 09:56:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221108, encodeId=9dca12211085b, content=挺有用的,刚发现这个APP, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1556233736, createdName=155755_9823, createdTime=Fri May 20 09:50:14 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-05-27 蒋师兄

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1238388, encodeId=2ce51238388b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff938274145, createdName=ms5000002136736266, createdTime=Fri Aug 12 22:49:44 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223858, encodeId=47bf12238589a, content=点个赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Wed Jun 01 15:14:55 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222810, encodeId=0a7c122281044, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/73dbf0704dfb6999779d37bdce402b75.jpg, createdBy=4d1f5252601, createdName=蒋师兄, createdTime=Fri May 27 15:31:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222752, encodeId=6b301222e524f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri May 27 09:56:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221108, encodeId=9dca12211085b, content=挺有用的,刚发现这个APP, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1556233736, createdName=155755_9823, createdTime=Fri May 20 09:50:14 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-05-27 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1238388, encodeId=2ce51238388b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff938274145, createdName=ms5000002136736266, createdTime=Fri Aug 12 22:49:44 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223858, encodeId=47bf12238589a, content=点个赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Wed Jun 01 15:14:55 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222810, encodeId=0a7c122281044, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/73dbf0704dfb6999779d37bdce402b75.jpg, createdBy=4d1f5252601, createdName=蒋师兄, createdTime=Fri May 27 15:31:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222752, encodeId=6b301222e524f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri May 27 09:56:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221108, encodeId=9dca12211085b, content=挺有用的,刚发现这个APP, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1556233736, createdName=155755_9823, createdTime=Fri May 20 09:50:14 CST 2022, time=2022-05-20, status=1, ipAttribution=)]
    2022-05-20 155755_9823

    挺有用的,刚发现这个APP

    0